Implementing drug checking as an illicit drug market intervention within the supply chain in a Canadian setting

References

• Bardwell, G., Boyd, J., Arredondo, J., McNeil, R., & Kerr, T. (2019). Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking. Drug and Alcohol Dependence, 198, 1–6. https://doi.org/10.1016/j.drugalcdep.2019.01.035
   PubMed Web of Science ®Google Scholar
• Barratt, M. J., Kowalski, M., Maier, L. J., & Ritter, A. (2018). Global review of drug checking services operating in 2017. National Drug & Alcohol Research Centre, UNSW.
   Google Scholar
• BC Coroners Service (2020). Illicit drug toxicity deaths in BC. BC Coroners Service.
   Google Scholar
• Beletsky, L., & Davis, C. S. (2017). Today’s fentanyl crisis: Prohibition’s Iron Law, revisited. The International Journal on Drug Policy, 46, 156–159. https://doi.org/10.1016/j.drugpo.2017.05.050
   PubMed Web of Science ®Google Scholar
• Betsos, A., Valleriani, J., Boyd, J., Bardwell, G., Kerr, T., & McNeil, R. (2021). “I couldn't live with killing one of my friends or anybody”: A rapid ethnographic study of drug sellers’ use of drug checking. The International Journal on Drug Policy, 87, 102845. https://doi.org/10.1016/j.drugpo.2020.102845
   PubMed Web of Science ®Google Scholar
• Bonn, M., Palayew, A., Bartlett, S., Brothers, T. D., Touesnard, N., & Tyndall, M. (2020). Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: The potential roles for decriminalization and safe supply. Journal of Studies on Alcohol and Drugs, 81(5), 556–560. https://doi.org/10.15288/jsad.2020.81.556
   PubMed Web of Science ®Google Scholar
• Borden, S. A., Saatchi, A., Vandergrift, G. W., Palaty, J., Lysyshyn, M., & Gill, C. G. (2022). A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry. Drug and Alcohol Review, 41(2), 410–418. https://doi.org/10.1111/dar.13370
   PubMed Web of Science ®Google Scholar
• Bowles, J. M., McDonald, K., Maghsoudi, N., Thompson, H., Stefan, C., Beriault, D. R., Delaney, S., Wong, E., & Werb, D. (2021). Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: Clinical and social implications. Harm Reduction Journal, 18(1), 1–6. https://doi.org/10.1186/s12954-021-00546-9
   PubMed Web of Science ®Google Scholar
• Carroll, J. J. (2021). Auras of detection: Power and knowledge in drug prohibition. Contemporary Drug Problems, 48(4), 327–345. https://doi.org/10.1177/00914509211035487
   Google Scholar
• Ciccarone, D. (2019). The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. The International Journal on Drug Policy, 71, 183–188. https://doi.org/10.1016/j.drugpo.2019.01.010
   PubMed Web of Science ®Google Scholar
• Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017). Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’. The International Journal on Drug Policy, 46, 146–155. https://doi.org/10.1016/j.drugpo.2017.06.004
   PubMed Web of Science ®Google Scholar
• Collins, A. B., Boyd, J., Mayer, S., Fowler, A., Kennedy, M. C., Bluthenthal, R. N., Kerr, T., & McNeil, R. (2019). Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites. The International Journal on Drug Policy, 73, 199–207. https://doi.org/10.1016/j.drugpo.2019.08.002
   PubMed Web of Science ®Google Scholar
• Collins, A. B., Ndoye, C. D., Arene-Morley, D., & Marshall, B. D. L. (2020). Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19. The International Journal on Drug Policy, 83, 102872. https://doi.org/10.1016/j.drugpo.2020.102872
   PubMed Web of Science ®Google Scholar
• Corbin, J., & Strauss, A. (1990). Basics of qualitative research: Grounded Theory procedures and techniques.
   Google Scholar
• Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., Hart, C., Kerr, T., Lajous, A. M., Lewis, S., Martin, N., Mejía, D., Camacho, A., Mathieson, D., Obot, I., … Beyrer, C. (2016). Public health and international drug policy. The Lancet, 387(10026), 1427–1480. https://doi.org/10.1016/S0140-6736(16)00619-X
   PubMed Web of Science ®Google Scholar
• Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science, 4(1), 50. https://doi.org/10.1186/1748-5908-4-50
   PubMed Web of Science ®Google Scholar
• Del Pozo, B., & Beletsky, L. (2020). No “back to normal” after COVID-19 for our failed drug policies. The International Journal on Drug Policy, 83, 102901. https://doi.org/10.1016/j.drugpo.2020.102901
   PubMed Web of Science ®Google Scholar
• Dwyer, R., Olsen, A., Fowlie, C., Gough, C., van Beek, I., Jauncey, M., Lintzeris, N., Oh, G., Dicka, J., Fry, C. L., Hayllar, J., & Lenton, S. (2018). An overview of take‐home naloxone programs in Australia. Drug and Alcohol Review, 37(4), 440–449. https://doi.org/10.1111/dar.12812
   PubMed Web of Science ®Google Scholar
• Gozdzialski, L., Aasen, J., Larnder, A., Ramsay, M., Borden, S. A., Saatchi, A., Gill, C. G., Wallace, B., & Hore, D. K. (2021). Portable gas chromatography–mass spectrometry in drug checking: Detection of carfentanil and etizolam in expected opioid samples. The International Journal on Drug Policy, 97, 103409. https://doi.org/10.1016/j.drugpo.2021.103409
   PubMed Web of Science ®Google Scholar
• Gozdzialski, L., Ramsay, M., Larnder, A., Wallace, B., & Hore, D. K. (2021). Fentanyl detection and quantification using portable Raman spectroscopy in community drug checking. Journal of Raman Spectroscopy, 52(7), 1308–1316. https://doi.org/10.1002/jrs.6133
   Web of Science ®Google Scholar
• Grebely, J., Cerdá, M., & Rhodes, T. (2020). COVID-19 and the health of people who use drugs: What is and what could be? The International Journal on Drug Policy, 83, 102958. https://doi.org/10.1016/j.drugpo.2020.102958
   PubMed Web of Science ®Google Scholar
• Green, T. C., Park, J. N., Gilbert, M., McKenzie, M., Struth, E., Lucas, R., Clarke, W., & Sherman, S. G. (2020). An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. The International Journal on Drug Policy, 77, 102661. https://doi.org/10.1016/j.drugpo.2020.102661
   PubMed Web of Science ®Google Scholar
• Greer, A. M., Amlani, A., Burmeister, C., Scott, A., Newman, C., Lampkin, H., Pauly, B., & Buxton, J. A. (2019). Peer engagement barriers and enablers: Insights from people who use drugs in British Columbia. Canadian Journal of Public Health, 110(2), 227–235. https://doi.org/10.17269/s41997-018-0167-x
   PubMed Web of Science ®Google Scholar
• Groves, A. (2018). ‘Worth the test?’ Pragmatism, pill testing and drug policy in Australia. Harm Reduction Journal, 15(1), 12. https://doi.org/10.1186/s12954-018-0216-z
   PubMed Web of Science ®Google Scholar
• Henry, B. (2019). Stopping the harm: Decriminalization of people who use drugs in BC. Office of the Provincial Health Officer. https://www2.gov.bc.ca/assets/gov/health/about-bc-s-health-care-system/office-of-the-provincial-health-officer/reports-publications/special-reports/stopping-the-harm-report.pdf
   Google Scholar
• Karamouzian, M., Papamihali, K., Graham, B., Crabtree, A., Mill, C., Kuo, M., Young, S., & Buxton, J. A. (2020). Known fentanyl use among clients of harm reduction sites in British Columbia. The International Journal on Drug Policy, 77, 102665. https://doi.org/10.1016/j.drugpo.2020.102665
   PubMed Web of Science ®Google Scholar
• Kolla, G., & Strike, C. (2020). Practices of care among people who buy, use, and sell drugs in community settings. Harm Reduction Journal, 17(1), 1–12. https://doi.org/10.1186/s12954-020-00372-5
   PubMed Web of Science ®Google Scholar
• Laing, M. K., Ti, L., Marmel, A., Tobias, S., Shapiro, A. M., Laing, R., Lysyshyn, M., & Socías, M. E. (2021). An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods. International Journal of Drug Policy, 93, 103169. https://doi.org/10.1016/j.drugpo.2021.103169
   PubMed Web of Science ®Google Scholar
• Larnder, A., Burek, P., Wallace, B., & Hore, D. K. (2021). Third party drug checking: accessing harm reduction services on the behalf of others. Harm Reduction Journal, 18(1), 1–4.
   PubMed Web of Science ®Google Scholar
• Lockwood, T.-L E., Vervoordt, A., & Lieberman, M. (2021). High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduction Journal, 18(1), 1–9. https://doi.org/10.1186/s12954-021-00478-4
   PubMed Web of Science ®Google Scholar
• Maghsoudi, N., McDonald, K., Stefan, C., Beriault, D. R., Mason, K., Barnaby, L., Altenberg, J., MacDonald, R. D., Caldwell, J., Nisenbaum, R., Leece, P., Watson, T. M., Tupper, K. W., Kufner, L., Scheim, A. I., Werb, D., & Drug Checking Services in Toronto Working Group (2020). Evaluating networked drug checking services in Toronto, Ontario: Study protocol and rationale. Harm Reduction Journal, 17(1), 9–10. https://doi.org/10.1186/s12954-019-0336-0
   PubMed Web of Science ®Google Scholar
• McCrae, K., Tobias, S., Grant, C., Lysyshyn, M., Laing, R., Wood, E., & Ti, L. (2020). Assessing the limit of detection of Fourier‐transform infrared spectroscopy and immunoassay strips for fentanyl in a real‐world setting. Drug and Alcohol Review, 39(1), 98–102. https://doi.org/10.1111/dar.13004
   PubMed Web of Science ®Google Scholar
• McCrae, K., Wood, E., Lysyshyn, M., Tobias, S., Wilson, D., Arredondo, J., & Ti, L. (2020). The utility of visual appearance in predicting the composition of street opioids. Substance Abuse, 39(1), 1–9.
   Google Scholar
• Measham, F. (2020). City checking: Piloting the UK's first community‐based drug safety testing (‘drug checking’) service in two city centres. British Journal of Clinical Pharmacology, 86(3), 420–428. https://doi.org/10.1111/bcp.14231
   PubMed Web of Science ®Google Scholar
• Moustaqim-Barrette, A., Papamihali, K., Mamdani, Z., Williams, S., & Buxton, J. A. (2020). Accessing take-home naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data. PLoS One, 15(9), e0238618. https://doi.org/10.1371/journal.pone.0238618
   PubMed Web of Science ®Google Scholar
• Olding, M., Barker, A., McNeil, R., & Boyd, J. (2021). Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19. The International Journal on Drug Policy, 90, 103076. https://doi.org/10.1016/j.drugpo.2020.103076
   PubMed Web of Science ®Google Scholar
• Park, J. N., Frankel, S., Morris, M., Dieni, O., Fahey-Morrison, L., Luta, M., Hunt, D., Long, J., & Sherman, S. G. (2021). Evaluation of fentanyl test strip distribution in two mid-Atlantic syringe services programs. The International Journal on Drug Policy, 94, 103196. https://doi.org/10.1016/j.drugpo.2021.103196
   PubMed Web of Science ®Google Scholar
• Park, J. N., Rouhani, S., Beletsky, L., Vincent, L., Saloner, B., & Sherman, S. G. (2020). Situating the continuum of overdose risk in the social determinants of health: A new conceptual framework. The Milbank Quarterly, 98(3), 700–746. https://doi.org/10.1111/1468-0009.12470
   PubMed Web of Science ®Google Scholar
• Pauly, B. B., Mamdani, Z., Mesley, L., McKenzie, S., Cameron, F., Edwards, D., Howell, A., Knott, M., Scott, T., Seguin, R., Greer, A. M., & Buxton, J. A. (2021). “It's an emotional roller coaster… But sometimes it's fucking awesome”: Meaning and motivation of work for peers in overdose response environments in British Columbia. The International Journal on Drug Policy, 88, 103015. https://doi.org/10.1016/j.drugpo.2020.103015
   PubMed Web of Science ®Google Scholar
• Pauly, B., Wallace, B., Pagan, F., Phillips, J., Wilson, M., Hobbs, H., & Connolly, J. (2020). Impact of overdose prevention sites during a public health emergency in Victoria, Canada. PLoS One, 15(5), e0229208. https://doi.org/10.1371/journal.pone.0229208
   PubMed Web of Science ®Google Scholar
• Ramsay, M., Gozdzialski, L., Larnder, A., Wallace, B., & Hore, D. (2021). Fentanyl quantification using portable infrared absorption spectroscopy. A framework for community drug checking. Vibrational Spectroscopy, 114, 103243. https://doi.org/10.1016/j.vibspec.2021.103243
   Web of Science ®Google Scholar
• Ti, L., Tobias, S., Maghsoudi, N., Milloy, M. J., McDonald, K., Shapiro, A., Beriault, D., Stefan, C., Lysyshyn, M., & Werb, D. (2021). Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings. Drug and Alcohol Review, 40(4), 580–585. https://doi.org/10.1111/dar.13237
   PubMed Web of Science ®Google Scholar
• Virani, H. N., & Haines-Saah, R. J. (2020). Drug decriminalization: A matter of justice and equity, not just health. American Journal of Preventive Medicine, 58(1), 161–164. https://doi.org/10.1016/j.amepre.2019.08.012
   PubMed Web of Science ®Google Scholar
• Wallace, B., Hills, R., Rothwell, J., Kumar, D., Garber, I., van Roode, T., Larnder, A., Pagan, F., Aasen, J., Weatherston, J., Gozdzialski, L., Ramsay, M., Burek, P., Azam, M. S., Pauly, B., Storey, M.-A., & Hore, D. (2021). Implementing an integrated multi‐technology platform for drug checking: Social, scientific, and technological considerations. Drug Testing and Analysis, 13(4), 734–746. https://doi.org/10.1002/dta.3022
   PubMed Web of Science ®Google Scholar
• Wallace, B., Pagan, F., & Pauly, B. (2019). The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. The International Journal on Drug Policy, 66, 64–72. https://doi.org/10.1016/j.drugpo.2019.01.017
   PubMed Web of Science ®Google Scholar
• Wallace, B., van Roode, T., Pagan, F., Hore, D., & Pauly, B. (2021). The potential impacts of community drug checking within the overdose crisis: Qualitative study exploring the perspective of prospective service users. BMC Public Health, 21(1), 1–12. https://doi.org/10.1186/s12889-021-11243-4
   PubMed Web of Science ®Google Scholar
• Wallace, B., van Roode, T., Pagan, F., Phillips, P., Wagner, H., Calder, S., Aasen, J., Pauly, B., & Hore, D. (2020). What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduction Journal, 17(1), 1–14. https://doi.org/10.1186/s12954-020-00373-4
   PubMed Web of Science ®Google Scholar
• Weicker, N. P., Owczarzak, J., Urquhart, G., Park, J. N., Rouhani, S., Ling, R., Morris, M., & Sherman, S. G. (2020). Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market. International Journal of Drug Policy, 84, 102900. https://doi.org/10.1016/j.drugpo.2020.102900
   PubMed Web of Science ®Google Scholar
• Wilson, N. G., Raveendran, J., & Docoslis, A. (2021). Portable identification of fentanyl analogues in drugs using surface-enhanced Raman scattering. Sensors and Actuators B: Chemical, 330, 129303. https://doi.org/10.1016/j.snb.2020.129303
   Web of Science ®Google Scholar